Residual chemoresistant, slow-cycling cancer cells (SCCs) regulate CAFs through multiple pathways, including COL1A1-mediated signaling pathways, to establish a growth-promoting TME for SCCs, restoring the proliferative capacity of quiescent non-small cell lung cancer cells. Here, COL1A1 is linked to cancer.